Francesca Salvianti
Overview
Explore the profile of Francesca Salvianti including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
48
Citations
908
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lavacchi D, Gelmini S, Calabri A, Rossi G, Simi L, Caliman E, et al.
Heliyon
. 2023 Nov;
9(11):e21853.
PMID: 38027900
The detection of RAS mutations and co-mutations in liquid biopsy offers a novel paradigm for the dynamic management of metastatic colorectal cancer (mCRC) patients. Expanding the results of the prospective...
2.
Castaman G, Linari S, Pieri L, Carulli C, Prosperi P, Tonelli P, et al.
J Clin Med
. 2023 Mar;
12(6).
PMID: 36983317
Emicizumab is a humanized recombinant bispecific antibody, bridging together activated factor IX (FIXa) and factor X (FX), thus mimicking the activity of FVIII in vivo. Emicizumab is designed for long-term...
3.
Francolini G, Loi M, Ciccone L, Detti B, Di Cataldo V, Pinzani P, et al.
Med Oncol
. 2022 Jun;
39(8):119.
PMID: 35687207
Circulating tumor cells detection and ARV7 expression are associated with worse clinical outcomes in metastatic Castration-Resistant Prostate Cancer (mCRPC) undergoing Androgen Receptor Targeted Agents. ARFL, PSMA and PSA may help...
4.
Salvianti F, Gelmini S, Mancini I, Pazzagli M, Pillozzi S, Giommoni E, et al.
Br J Cancer
. 2021 May;
125(1):94-100.
PMID: 33953347
Background: Within the OMITERC prospective study (OMIcs application from solid to liquid biopsy for a personalised ThERapy of Cancer), we explored the prognostic role of liquid biopsy encompassing cell-free DNA...
5.
Pinzani P, DArgenio V, Del Re M, Pellegrini C, Cucchiara F, Salvianti F, et al.
Clin Chem Lab Med
. 2021 Feb;
59(7):1181-1200.
PMID: 33544478
Despite advances in screening and therapeutics cancer continues to be one of the major causes of morbidity and mortality worldwide. The molecular profile of tumor is routinely assessed by surgical...
6.
Cantini G, Canu L, Armignacco R, Salvianti F, De Filpo G, Ercolino T, et al.
Cancers (Basel)
. 2020 Nov;
12(11).
PMID: 33138000
Adrenocortical carcinoma (ACC), a rare and aggressive neoplasia, presents poor prognosis when metastatic at diagnosis and limited therapies are available. Specific and sensitive markers for early diagnosis and a monitoring...
7.
Villari D, Salvianti F, Zanazzi M, Martini A, Spatafora P, Caroassai Grisanti S, et al.
Urol Int
. 2020 Sep;
104(11-12):865-870.
PMID: 32957110
Introduction: Microchimerism (MC) is the presence of a small amount of foreign cells or DNA within a person's circulation or tissues. It has been identified also in recipients of solid...
8.
Cito G, Coccia M, Salvianti F, Fucci R, Picone R, Giachini C, et al.
Andrology
. 2020 May;
8(5):1256-1264.
PMID: 32406197
Background: Recently, alterations in miRNAs expression profile in semen have been linked to damaged spermatogenesis, suggesting miRNAs could be used as potential infertility biomarkers. In previous animal studies, miR-20a-5p was...
9.
Salvianti F, Gelmini S, Costanza F, Mancini I, Sonnati G, Simi L, et al.
N Biotechnol
. 2019 Oct;
55:19-29.
PMID: 31580920
The term 'liquid biopsy', introduced in 2013 in reference to the analysis of circulating tumour cells (CTCs) in cancer patients, was extended to cell-free nucleic acids (cfNAs) circulating in blood...
10.
Salvianti F, Costanza F, Sonnati G, Pinzani P
Methods Mol Biol
. 2019 Oct;
2065:139-151.
PMID: 31578693
We propose two different approaches involving the use of quantitative real-time PCR for the detection or analysis of circulating tumor cells. In one case cells are indirectly identified through the...